Teva- Pharmaceutical Industries Ltd. ADR’s recent filing unveils that its Shareholder Bridger Management, LLC (1) acquired Company’s shares for reported $4.53 million on Dec 12 ’25. In the deal valued at $30.18 per share,150,000 shares were bought.
Then, Daniell Richard sold 115,468 shares, generating $3,311,126 in total proceeds. Upon selling the shares at $28.68, the Exec. VP, European Commercial now owns 48,384 shares.
Before that, Sabag Mark sold 216,892 shares. Teva- Pharmaceutical Industries Ltd. ADR shares valued at $6,230,754 were divested by the See “Remarks” at a price of $28.73 per share. As a result of the transaction, Sabag Mark now holds 52,828 shares, worth roughly $1.57 million.
Barclays initiated its Teva- Pharmaceutical Industries Ltd. ADR [TEVA] rating to an Overweight in a research note published on December 09, 2025; the price target was $35. A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in early December with a ‘”a Sector outperform”‘ rating. Goldman began covering TEVA with “Buy” recommendation on June 06, 2025. Truist started covering the stock on May 28, 2025. It rated TEVA as “a Buy”.
Price Performance Review of TEVA
On Friday, Teva- Pharmaceutical Industries Ltd. ADR [NYSE:TEVA] saw its stock fall -1.29% to $29.79. Over the last five days, the stock has gained 4.67%. Teva- Pharmaceutical Industries Ltd. ADR shares have risen nearly 71.70% since the year began. Nevertheless, the stocks have risen 35.16% over the past one year. While a 52-week high of $30.20 was reached on 12/11/25, a 52-week low of $12.47 was recorded on 04/10/25.
Levels Of Support And Resistance For TEVA Stock
The 24-hour chart illustrates a support level at 29.52, which if violated will result in even more drops to 29.25. On the upside, there is a resistance level at 30.09. A further resistance level may holdings at 30.40.
How much short interest is there in Teva- Pharmaceutical Industries Ltd. ADR?
A steep rise in short interest was recorded in Teva- Pharmaceutical Industries Ltd. ADR stocks on 2025-11-28, dropping by -4.77 million shares to a total of 45.62 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-31 was 50.39 million shares. There was a decline of -10.46%, which implies that there is a negative sentiment for the stock.
